Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Potential drug targets for intracranial aneurysms identified through Mendelian randomization analysis

Submitted by Anna Hakala on Thu, 10/16/2025 - 11:22
  • Read more about Potential drug targets for intracranial aneurysms identified through Mendelian randomization analysis

Causal Relationship Between Brain Functional Networks and Sleep Disorders: A Mendelian Randomization Study

Submitted by Anna Hakala on Thu, 10/16/2025 - 11:20
  • Read more about Causal Relationship Between Brain Functional Networks and Sleep Disorders: A Mendelian Randomization Study

Identification of genetically-supported new drug targets for osteomyelitis based on druggable genomes

Submitted by Anna Hakala on Thu, 10/16/2025 - 11:18
  • Read more about Identification of genetically-supported new drug targets for osteomyelitis based on druggable genomes

Genetic variants of glucose-dependent insulinotropic polypeptide (GIP) signalling as proxy for body weight reduction and cardiovascular risk

Submitted by Anna Hakala on Thu, 10/16/2025 - 11:16
  • Read more about Genetic variants of glucose-dependent insulinotropic polypeptide (GIP) signalling as proxy for body weight reduction and cardiovascular risk

Association Between Specific Sleep Traits and Four Inflammatory Skin Diseases: A Mendelian Randomization Study

Submitted by Anna Hakala on Thu, 10/16/2025 - 11:08
  • Read more about Association Between Specific Sleep Traits and Four Inflammatory Skin Diseases: A Mendelian Randomization Study

Plasma Proteome Profiling Identifies Biomarkers and Potential Drug Targets for Non-Small Cell Lung Cancer

Submitted by Anna Hakala on Thu, 10/16/2025 - 11:01
  • Read more about Plasma Proteome Profiling Identifies Biomarkers and Potential Drug Targets for Non-Small Cell Lung Cancer

Integrated multi-omics profiling reveals shared mechanistic pathways in asthma-allergic rhinitis comorbidity: A hybrid machine learning framework leveraging Mendelian randomization for precision diagnostics

Submitted by Anna Hakala on Thu, 10/16/2025 - 10:52
  • Read more about Integrated multi-omics profiling reveals shared mechanistic pathways in asthma-allergic rhinitis comorbidity: A hybrid machine learning framework leveraging Mendelian randomization for precision diagnostics

Identification of Plasma Protein Biomarkers and Drug Targets for Hematologic Malignancies by Proteome-wide Mendelian Randomization

Submitted by Anna Hakala on Thu, 10/16/2025 - 10:47
  • Read more about Identification of Plasma Protein Biomarkers and Drug Targets for Hematologic Malignancies by Proteome-wide Mendelian Randomization

Multipopulation GWAS for venous thromboembolism identifies novel loci followed by experimental validation in zebrafish

Submitted by Anna Hakala on Wed, 10/08/2025 - 09:29
  • Read more about Multipopulation GWAS for venous thromboembolism identifies novel loci followed by experimental validation in zebrafish

Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study

Submitted by Anna Hakala on Tue, 10/07/2025 - 10:16
  • Read more about Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 49
  • Page 50
  • Page 51
  • Page 52
  • Current page 53
  • Page 54
  • Page 55
  • Page 56
  • Page 57
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement